title: p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
abstract: OBJECTIVE
  A small number of chronic myeloproliferative disorders with hematologic features of chronic myelomonocytic leukemia (CMML) or atypical chronic myeloid leukemia and Ph1 chromosome with m-BCR rearrangement have been reported (p190 CMPD). We report here 3 new cases of p190 CMPD that had unusual features. In 2 of the cases the m-BCR rearrangement appeared to be a secondary event.
  
  
  METHODS
  Patients were studied by cytogenetic, FISH, and molecular biology analyses and followed-up clinically.
  
  
  RESULTS
  The first patient initially had typical 5q- syndrome, without m-BCR rearrangement. Five years later, she developed hematologic features of CMML, with t(9;22) translocation, m-BCR rearrangement and high levels of p190 BCR-ABL transcript. The second patient initially had hematologic characteristics of chronic myeloid leukemia (CML) with t(9;22) translocation and m-BCR rearrangement but also other complex cytogenetic findings including 17p rearrangement. Monocytosis developed during the course of the disease. The third patient initially had agnogenic myeloid metaplasia (AMM). Five years later, while the hematologic characteristics were still those of AMM, a first karyotype showed a t(9;22) translocation and molecular analysis showed a very low level of p190 BCR-ABL transcript. Four years later, the patient developed hematologic features of atypical CML with blood monocytosis, t(9;22) and much greater (100 fold) p190 BCR-ABL transcript levels.
  
  
  CONCLUSIONS
  Our 3 cases and review of the previously published cases show the variability of clinical features of p190 positive CMPD. Our results also suggest that, at least in some cases, p190 BCR-ABL rearrangement could be a secondary event in the course of a myeloid disorder.
authors.affiliation: Laboratoire d'Hématologie A, Centre Hospitalier Universitaire of Lille, France.
authors.forename: C
authors.initials: C
authors.lastname: Roumier
authors.forename: A
authors.initials: A
authors.lastname: Daudignon
authors.forename: V
authors.initials: V
authors.lastname: Soenen
authors.forename: B
authors.initials: B
authors.lastname: Dupriez
authors.forename: M
authors.initials: M
authors.lastname: Wetterwald
authors.forename: J L
authors.initials: JL
authors.lastname: Lai
authors.forename: A
authors.initials: A
authors.lastname: Cosson
authors.forename: P
authors.initials: P
authors.lastname: Fenaux
authors.forename: C
authors.initials: C
authors.lastname: Preudhomme
mesh_terms: D002892:Chromosomes, Human, Pair 22; D002899:Chromosomes, Human, Pair 9; D003582:Cytogenetics; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D015321:Gene Rearrangement; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology / Q000235:genetics; D008297:Male; D008875:Middle Aged; D010677:Philadelphia Chromosome; D014178:Translocation, Genetic
chemical_list: D016044:Fusion Proteins, bcr-abl